Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naive Subjects in Hunan Province, China

被引:13
|
作者
Zou Xiaobai [1 ]
Xi, Chen [1 ]
Tian, Hongping [2 ]
Williams, Ann B. [3 ]
Wang, Honghong [4 ]
He, Jianmei [1 ]
Zhen, Jun [1 ]
Chiarella, Jennifer [5 ]
Blake, Lisebeth A. [6 ]
Turenchalk, Gregory [6 ]
Kozal, Michael J. [5 ]
机构
[1] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China
[2] Yale China Assoc, New Haven, CT USA
[3] UCLA Sch Nursing, Los Angeles, CA USA
[4] Cent S Univ, Changsha, Hunan, Peoples R China
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] 454 Life Sci, Branford, CT USA
来源
PLOS ONE | 2014年 / 9卷 / 06期
关键词
REVERSE-TRANSCRIPTASE INHIBITORS; MINORITY POPULATIONS; HIV-1; VARIANTS; THERAPY; FAILURE; GENOME;
D O I
10.1371/journal.pone.0098740
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There are few data on the prevalence of WHO transmitted drug resistance mutations (TDRs) that could affect treatment responses to first line antiretroviral therapy (ART) in Hunan Province, China. Objective: Determine the prevalence of WHO NRTI/NNRTI/PI TDRs in ART-naive subjects in Hunan Province by deep sequencing. Methods: ART-naive subjects diagnosed in Hunan between 2010-2011 were evaluated by deep sequencing for low-frequency HIV variants possessing WHO TDRs to 1% levels. Mutations were scored using the HIVdb.stanford.edu algorithm to infer drug susceptibility. Results: Deep sequencing was performed on samples from 90 ART-naive subjects; 83.3% were AE subtype. All subjects had advanced disease (average CD4 count 134 cells/mm(3)). Overall 25.6%(23/90) of subjects had HIV with major WHO NRTI/NNRTI TDRs by deep sequencing at a variant frequency level >= 1%; 16.7%(15/90) had NRTI TDR and 12.2%(11/90) had a major NNRTI TDR. The majority of NRTI/NNRTI mutations were identified at variant levels <5%. Mutations were analyzed by HIVdb.stanford.edu and 7.8% of subjects had variants with high-level nevirapine resistance; 4.4% had high-level NRTI resistance. Deep sequencing identified 24(27.6%) subjects with variants possessing either a PI TDR or hivdb.stanford.edu PI mutation (algorithm value >= 15). 17(19.5%) had PI TDRs at levels >1%. Conclusions: ART-naive subjects from Hunan Province China infected predominantly with subtype AE frequently possessed HIV variants with WHO NRTI/NNRTI TDRs by deep sequencing that would affect the first line ART used in the region. Specific mutations conferring nevirapine high-level resistance were identified in 7.8% of subjects. The majority of TDRs detected were at variant levels <5% likely due to subjects having advanced chronic disease at the time of testing. PI TDRs were identified frequently, but were found in isolation and at low variant frequency. As PI/r use is infrequent in Hunan, the existence of PI mutations likely represent AE subtype natural polymorphism at low variant level frequency.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France
    Descamps, Diane
    Chaix, Marie-Laure
    Montes, Brigitte
    Pakianather, Sophie
    Charpentier, Charlotte
    Storto, Alexandre
    Barin, Francis
    Dos Santos, Georges
    Krivine, Anne
    Delaugerre, Constance
    Izopet, Jacques
    Marcelin, Anne-Genevieve
    Maillard, Anne
    Morand-Joubert, Laurence
    Pallier, Coralie
    Plantier, Jean-Christophe
    Tamalet, Catherine
    Cottalorda, Jacqueline
    Desbois, Delphine
    Calvez, Vincent
    Brun-Vezinet, Francoise
    Masquelier, Bernard
    Costagliola, Dominique
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (12) : 2620 - 2627
  • [32] Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998:: a French nationwide study
    Descamps, D
    Calvez, V
    Izopet, J
    Bluffet-Janvresse, C
    Schmuck, A
    Colson, P
    Ruffault, A
    Maillard, A
    Masquelier, B
    Cottalorda, J
    Harzic, M
    Brun-Vézinet, F
    Costagliola, D
    AIDS, 2001, 15 (14) : 1777 - 1782
  • [33] Drug Resistance Mutations in the HIV Type 1 Protease and Reverse Transcriptase Genes in Antiretroviral-Naive Vietnamese Children
    Quang Duy Trinh
    Ngan Thi Kim Pham
    Nhut Tin Le Nguyen
    Bao Quoc Lam
    Kim Thoa Le Phan
    Khanh Huu Truong
    Izumi, Yasuyuki
    Komine-Aizawa, Shihoko
    Mizuguchi, Masashi
    Ushijima, Hiroshi
    Hayakawa, Satoshi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (10) : 1305 - 1307
  • [34] HIV Type 1 Subtypes Based on the pol Gene and Drug Resistance Mutations Among Antiretroviral-Naive Patients from Guangxi, Southern China
    Su, Qijian
    Liang, Hao
    Cen, Ping
    Bi, Zhiyou
    Zhou, Ping
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (07) : 725 - 728
  • [35] Low prevalence of antiretroviral drug resistance mutations in drug naive patients with established HIV infection in the UK
    Burke, A
    Thorne, N
    Loveday, C
    AIDS, 2000, 14 : S121 - S122
  • [36] The prevalence of transmitted HIV drug resistance among MSM in Anhui province, China
    Yuelan Shen
    Bin Su
    Jianjun Wu
    Yizu Qin
    Lin Jin
    Lifeng Miao
    Aiwen Liu
    Xiaoli Cheng
    AIDS Research and Therapy, 11
  • [37] The prevalence of transmitted HIV drug resistance among MSM in Anhui province, China
    Shen, Yuelan
    Su, Bin
    Wu, Jianjun
    Qin, Yizu
    Jin, Lin
    Miao, Lifeng
    Liu, Aiwen
    Cheng, Xiaoli
    AIDS RESEARCH AND THERAPY, 2014, 11
  • [38] Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 2006/2007: a French nationwide study
    Descamps, D.
    Montes, B.
    Chaix, M. L.
    Pakianather, S.
    Barin, F.
    Dos Santos, G.
    Krivine, A.
    Delaugerre, C.
    Izopet, J.
    Marcelin, A. G.
    Maillard, A.
    Morand-Joubert, L.
    Pallier, C.
    Plantier, J. C.
    Tamalet, C.
    Calvez, V.
    Masquelier, B.
    Brun-Vezinet, F.
    Costagliola, D.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A154 - A154
  • [39] Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon
    Wenk, Benjamin M.
    Mbunkah, Herbert A.
    Nsanwe, Ndi N.
    Mbu, Eyongetah T.
    Besong, Lydia M.
    Sama, Bella A.
    Orock, Emmanuel
    Leemann, Christine
    Metzner, Karin J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (01) : 124 - 129
  • [40] Geographic and Temporal Trends of Transmitted HIV-1 Drug Resistance Among Antiretroviral-Naive Subjects Screening for Two Clinical Trials in North America and Western Europe
    Rahim, Sibtain
    Fredrick, Linda M.
    da Silva, Barbara A.
    Bernstein, Barry
    King, Martin S.
    HIV CLINICAL TRIALS, 2009, 10 (02): : 94 - 103